Empagliflozin/Linagliptin/Metformin | Interleukin Related interleukin-related.com

Product Name :
Empagliflozin/Linagliptin/Metformin

Search keywords :
CD26

drugId :
null

Target Vo:
Dipeptidyl peptidase IV

Target Vo Short Name :
DPP4

Moa_Name:
Protein kinase AMP-activated non-catalytic subunit beta 1 activators

First Approval Country :
United States

First Approval Date Filter:
2020

Origin Company_Name :
Boehringer Ingelheim Gmbh

Active Company_Name :
Boehringer Ingelheim Gmbh

Active Indication_Name:
Diabetes Mellitus, Type 2

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-GSK3 (Tyr216/Tyr279) Rabbit mAb Purity
MMP12 Rabbit mAb manufacturer
Caveolin-1 Antibody: Caveolin-1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 20 kDa, targeting to Caveolin-1. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts